GAMBARAN TINGKAT KEPATUHAN MINUM OBAT ANTIHIPERTENSI DI PUSKESMAS JATINANGOR
Article Sidebar
Published:
May 9, 2021
Keywords:
Hypertension, Compliance, Anti-Hypertension Drugs
Main Article Content
Abstract
Hypertension is the most common cardiovascular disease. This non-communicable disease cannot be cured but can be controlled by taking antihypertensive drugs regularly. Patient’s low compliance can be one of the factors that aggravates the patient's condition. This study aims to describe the proportion of patient’s adherence for taking antihypertensive drugs in Puskesmas Jatinangor using the Eight-Items Morisky Medication Adherence Scale (MMAS-8) questionnaire. This study was hold between September 2017 and August 2018 and was described using descriptive analytical method with crosssectional study design. From 74 respondents who participated in this study, we obtained the data in the form of sex, age, education level, marital status, occupation, income, payment media, hypertension duration, number of drugs consumed, type of medication, and motivational support. The data showed that 74 hypertensive patients in Puskesmas Jatinangor have a high compliance on taking antihypertensive drugs. We expect the results of this study can increase public awareness about drug compliance, especially for antihypertensive drugs in the working region of Puskesmas Jatinangor.
Article Details
How to Cite
Istiqomah, T., Ramadhanti, J., & Wahyudi, K. (2021). GAMBARAN TINGKAT KEPATUHAN MINUM OBAT ANTIHIPERTENSI DI PUSKESMAS JATINANGOR. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 7(1), 40-46. https://doi.org/10.53366/jimki.v7i1.396
Section
Research Article
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
1. Day WH. A Global Brief on
Hypertension World Health Day 2013.
2013;
2. Susan B Masters, Anthony J. Trevor
BGK. Katzungs Basic & Clinical
Pharmacology. 12th ed. Mc Graw Hill
Lange; 2012. 169 p
3. Badan Penelitian dan Pengembangan
Kesehatan. Riset Kesehatan Dasar
(Riskesdas) 2013. Lap Nas 2013.
2013;1–384.
4. Fihaya FY, Sofiatin Y, Ong PA,
Sukandar H, Roesli RMA. Prevalence
of Hypertension and Its Complications
in Jatinangor 2014. Vol. 33, Journal of
Hypertension. 2015. p. e35.
5. Dinas Kesehatan Sumedang. Profil
Kesehatan Kabupaten Sumedang
2016. MCAP Sumedang. Sumedang;
2016.
6. Dinas Kesehatan Jawa Barat. Profil
Kesehatan Jawa Barat. Bandung:
Dinas Kesehatan Jawa Barat; 2015.
7. Harijanto, W., Achmad, R., dan Arief,
A. N. Pengaruh konseling
motivational interviewing terhadap
kepatuhan minum obat penderita
hipertensi. Jurnal Kedokteran
Brawijaya. 2015, Vol. 28, No. 4.
8. Profil Kesehatan Kota Bandung.
Bandung: Dinas Kesehatan Kota
Bandung; 2016.
9. Van Rossum CTM, van de Mhen H,
Witteman JCM, Hoftnan A,
Mackenbach JP, Groobee DE.
Prevalence, treatment, and control of
hypertension by sociodemographic
factors among the dutch elderly.
Hypertension 2000;35:814-21.
10.Irazola VE, Gutierrez L, Bloomfield
GS, Carrillo-Larco RM, Dorairaj P,
Gaziano T, et al. Hypertension
prevalence, awareness, treatment,
and control in selected communities
of nine low and middle income
countries: Results from the NHLBI/
UHG Network of Centers of
Excellence for Chronic Diseases.
Glob Heart. 2016; 11(1):47–59.
11.Lopez JP, Camacho LPA, Arbelaez
DG, Alvarado L, Molina DI, Sanchez
G. PP.29.11: Educational level
influence in the prevalence,
awareness, treatment and control of
hypertension in Colombia. J
Hypertens. 2015;33:e392-3.
12.Lulebo AM, Mutombo PB, Mapatano
MA, Mafuta EM, Kayembe PK,
Ntumba LT. Predictors of nonadherence to antihypertensive
medication in Kinshasa, democratic 8. Profil Kesehatan Kota Bandung.
Bandung: Dinas Kesehatan Kota
Bandung; 2016.
9. Van Rossum CTM, van de Mhen H,
Witteman JCM, Hoftnan A,
Mackenbach JP, Groobee DE.
Prevalence, treatment, and control of
hypertension by sociodemographic
factors among the dutch elderly.
Hypertension 2000;35:814-21.
10.Irazola VE, Gutierrez L, Bloomfield
GS, Carrillo-Larco RM, Dorairaj P,
Gaziano T, et al. Hypertension
prevalence, awareness, treatment,
and control in selected communities
of nine low and middle income
countries: Results from the NHLBI/
UHG Network of Centers of
Excellence for Chronic Diseases.
Glob Heart. 2016; 11(1):47–59.
11.Lopez JP, Camacho LPA, Arbelaez
DG, Alvarado L, Molina DI, Sanchez
G. PP.29.11: Educational level
influence in the prevalence,
awareness, treatment and control of
hypertension in Colombia. J
Hypertens. 2015;33:e392-3.
12.Lulebo AM, Mutombo PB, Mapatano
MA, Mafuta EM, Kayembe PK,
Ntumba LT. Predictors of nonadherence to antihypertensive
medication in Kinshasa, democratic 8. Profil Kesehatan Kota Bandung.
Bandung: Dinas Kesehatan Kota
Bandung; 2016.
9. Van Rossum CTM, van de Mhen H,
Witteman JCM, Hoftnan A,
Mackenbach JP, Groobee DE.
Prevalence, treatment, and control of
hypertension by sociodemographic
factors among the dutch elderly.
Hypertension 2000;35:814-21.
10.Irazola VE, Gutierrez L, Bloomfield
GS, Carrillo-Larco RM, Dorairaj P,
Gaziano T, et al. Hypertension
prevalence, awareness, treatment,
and control in selected communities
of nine low and middle income
countries: Results from the NHLBI/
UHG Network of Centers of
Excellence for Chronic Diseases.
Glob Heart. 2016; 11(1):47–59.
11.Lopez JP, Camacho LPA, Arbelaez
DG, Alvarado L, Molina DI, Sanchez
G. PP.29.11: Educational level
influence in the prevalence,
awareness, treatment and control of
hypertension in Colombia. J
Hypertens. 2015;33:e392-3.
12.Lulebo AM, Mutombo PB, Mapatano
MA, Mafuta EM, Kayembe PK,
Ntumba LT. Predictors of nonadherence to antihypertensive
medication in Kinshasa, democratic Republic of Congo: A cross-sectional
study. BMC Res Notes. 2015;8: 526.
13.Prasetyo, Eko., Detari, Wijayanti,
Evaluasi Penggunaan Obat
Antihipertensi pada Penyakit
Hipertensi Disertai Gagal Ginjal
Kronik (ICD I12,0) Pasien Geriatri
Rawat Inap di RSUD A. W. Sjahranie
Samarinda pada Tahun 2012 dan
2013 dengan Metode ATC/DDD,
Jurnal Farmasi Indonesia, Vol.12 hal
23-32, 2015.
14.Triguna IPB, Sudhana IW. Gambaran
Kepatuhan Minum Obat
Antihipertensi Pada Pasien Hipertensi
di Wilayah Kerja Puskesmas Petang
II, Kabupaten Periode Juli-Agustus
2013
15.Ekarini D. Faktor-faktor yang
berhubungan dengan tingkat
kepatuhan klien hipertensi dalam
menjalani pengobatan di Puskesmas
Gondangrejo Karanganyar. Jurnal
KESMADASKA. 2012;3(1).
16.Sinuraya RK, Destiani DP,
Puspitasari IM, Diantini A.
Pengukuran Tingkat Kepatuhan
Pengobatan Pasien Hipertensi di
Fasilitas Kesehatan Tingkat Pertama
di Kota Bandung. Indonesian Journal
of Clinical Pharmacy. 2018 Jun
1;7(2):124
Hypertension World Health Day 2013.
2013;
2. Susan B Masters, Anthony J. Trevor
BGK. Katzungs Basic & Clinical
Pharmacology. 12th ed. Mc Graw Hill
Lange; 2012. 169 p
3. Badan Penelitian dan Pengembangan
Kesehatan. Riset Kesehatan Dasar
(Riskesdas) 2013. Lap Nas 2013.
2013;1–384.
4. Fihaya FY, Sofiatin Y, Ong PA,
Sukandar H, Roesli RMA. Prevalence
of Hypertension and Its Complications
in Jatinangor 2014. Vol. 33, Journal of
Hypertension. 2015. p. e35.
5. Dinas Kesehatan Sumedang. Profil
Kesehatan Kabupaten Sumedang
2016. MCAP Sumedang. Sumedang;
2016.
6. Dinas Kesehatan Jawa Barat. Profil
Kesehatan Jawa Barat. Bandung:
Dinas Kesehatan Jawa Barat; 2015.
7. Harijanto, W., Achmad, R., dan Arief,
A. N. Pengaruh konseling
motivational interviewing terhadap
kepatuhan minum obat penderita
hipertensi. Jurnal Kedokteran
Brawijaya. 2015, Vol. 28, No. 4.
8. Profil Kesehatan Kota Bandung.
Bandung: Dinas Kesehatan Kota
Bandung; 2016.
9. Van Rossum CTM, van de Mhen H,
Witteman JCM, Hoftnan A,
Mackenbach JP, Groobee DE.
Prevalence, treatment, and control of
hypertension by sociodemographic
factors among the dutch elderly.
Hypertension 2000;35:814-21.
10.Irazola VE, Gutierrez L, Bloomfield
GS, Carrillo-Larco RM, Dorairaj P,
Gaziano T, et al. Hypertension
prevalence, awareness, treatment,
and control in selected communities
of nine low and middle income
countries: Results from the NHLBI/
UHG Network of Centers of
Excellence for Chronic Diseases.
Glob Heart. 2016; 11(1):47–59.
11.Lopez JP, Camacho LPA, Arbelaez
DG, Alvarado L, Molina DI, Sanchez
G. PP.29.11: Educational level
influence in the prevalence,
awareness, treatment and control of
hypertension in Colombia. J
Hypertens. 2015;33:e392-3.
12.Lulebo AM, Mutombo PB, Mapatano
MA, Mafuta EM, Kayembe PK,
Ntumba LT. Predictors of nonadherence to antihypertensive
medication in Kinshasa, democratic 8. Profil Kesehatan Kota Bandung.
Bandung: Dinas Kesehatan Kota
Bandung; 2016.
9. Van Rossum CTM, van de Mhen H,
Witteman JCM, Hoftnan A,
Mackenbach JP, Groobee DE.
Prevalence, treatment, and control of
hypertension by sociodemographic
factors among the dutch elderly.
Hypertension 2000;35:814-21.
10.Irazola VE, Gutierrez L, Bloomfield
GS, Carrillo-Larco RM, Dorairaj P,
Gaziano T, et al. Hypertension
prevalence, awareness, treatment,
and control in selected communities
of nine low and middle income
countries: Results from the NHLBI/
UHG Network of Centers of
Excellence for Chronic Diseases.
Glob Heart. 2016; 11(1):47–59.
11.Lopez JP, Camacho LPA, Arbelaez
DG, Alvarado L, Molina DI, Sanchez
G. PP.29.11: Educational level
influence in the prevalence,
awareness, treatment and control of
hypertension in Colombia. J
Hypertens. 2015;33:e392-3.
12.Lulebo AM, Mutombo PB, Mapatano
MA, Mafuta EM, Kayembe PK,
Ntumba LT. Predictors of nonadherence to antihypertensive
medication in Kinshasa, democratic 8. Profil Kesehatan Kota Bandung.
Bandung: Dinas Kesehatan Kota
Bandung; 2016.
9. Van Rossum CTM, van de Mhen H,
Witteman JCM, Hoftnan A,
Mackenbach JP, Groobee DE.
Prevalence, treatment, and control of
hypertension by sociodemographic
factors among the dutch elderly.
Hypertension 2000;35:814-21.
10.Irazola VE, Gutierrez L, Bloomfield
GS, Carrillo-Larco RM, Dorairaj P,
Gaziano T, et al. Hypertension
prevalence, awareness, treatment,
and control in selected communities
of nine low and middle income
countries: Results from the NHLBI/
UHG Network of Centers of
Excellence for Chronic Diseases.
Glob Heart. 2016; 11(1):47–59.
11.Lopez JP, Camacho LPA, Arbelaez
DG, Alvarado L, Molina DI, Sanchez
G. PP.29.11: Educational level
influence in the prevalence,
awareness, treatment and control of
hypertension in Colombia. J
Hypertens. 2015;33:e392-3.
12.Lulebo AM, Mutombo PB, Mapatano
MA, Mafuta EM, Kayembe PK,
Ntumba LT. Predictors of nonadherence to antihypertensive
medication in Kinshasa, democratic Republic of Congo: A cross-sectional
study. BMC Res Notes. 2015;8: 526.
13.Prasetyo, Eko., Detari, Wijayanti,
Evaluasi Penggunaan Obat
Antihipertensi pada Penyakit
Hipertensi Disertai Gagal Ginjal
Kronik (ICD I12,0) Pasien Geriatri
Rawat Inap di RSUD A. W. Sjahranie
Samarinda pada Tahun 2012 dan
2013 dengan Metode ATC/DDD,
Jurnal Farmasi Indonesia, Vol.12 hal
23-32, 2015.
14.Triguna IPB, Sudhana IW. Gambaran
Kepatuhan Minum Obat
Antihipertensi Pada Pasien Hipertensi
di Wilayah Kerja Puskesmas Petang
II, Kabupaten Periode Juli-Agustus
2013
15.Ekarini D. Faktor-faktor yang
berhubungan dengan tingkat
kepatuhan klien hipertensi dalam
menjalani pengobatan di Puskesmas
Gondangrejo Karanganyar. Jurnal
KESMADASKA. 2012;3(1).
16.Sinuraya RK, Destiani DP,
Puspitasari IM, Diantini A.
Pengukuran Tingkat Kepatuhan
Pengobatan Pasien Hipertensi di
Fasilitas Kesehatan Tingkat Pertama
di Kota Bandung. Indonesian Journal
of Clinical Pharmacy. 2018 Jun
1;7(2):124